Form SC TO-I Sage Therapeutics, Inc. File

Form SC TO-I Sage Therapeutics, Inc. Filed by: Sage Therapeutics, Inc.

Form SC TO-I Sage Therapeutics, Inc. Filed by: Sage Therapeutics, Inc.

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Washington , United States , Cambridge , Cambridgeshire , United Kingdom , Massachusetts , Delaware , Jessicaj Federer , Anne Marie Cook , Steven Paul , Jeffreym Jonas , Barrye Greene , Jamesm Frates , Michaelf Cola , Christopher Benecchi , Kimi Iguchi , Laura Gault , Elizabeth Barrett , Geno Germano , George Golumbeski , Interest In Securities Of The Subject Company , Name Of Subject Company Issuer , Agreements Involving The Subject Company , Company Information , Procedures For Electing To Exchange Options , Members Of The Company , Exchange Eligible Options For Replacement , Sage Therapeutics Inc , Securities Exchange , Offering Memorandum For The Offer To Exchange , Party Tender , Offer Statement Under Section , Securities Exchange Act , Subject Company , Filing Person , Purchase Common Stock , Par Value , Chief Executive Officer , Telephone Number , Person Authorized , Receive Notices , Cross Border Issuer Tender Offer , Cross Border Third Party Tender Offer , Summary Term Sheet , Exchange Eligible Options , Replacement Options , Tender Offer Statement , Eligible Holders , Common Stock , Option Exchange , Eligible Option , Eligible Holder , Incentive Plan , Equity Plan , Equity Plans , Eligible Options , Replacement Option , Offer Expiration Date , Price Range , Common Stock Underlying , Offering Memorandum , Trading Market , Arrangements Concerning , Executive Officer , Financial Officer , Vice President , Exchange Options , Withdrawal Rights , Information Concerning Sage , Options Acquired , Accounting Consequences , Legal Matters , Regulatory Approvals , Income Tax Consequences , Agreements Involving , Additional Information , Pro Forma , Regulatory Requirements , Chief Executive ,